Abstract

Protein post-translational modifications (PTMs) are crucial for cancer cells to adapt to hypoxia; however, the functional significance of lysine crotonylation (Kcr) in hypoxia remains unclear. Herein we report a quantitative proteomics analysis of global crotonylome under normoxia and hypoxia, and demonstrate 128 Kcr site alterations across 101 proteins in MDA-MB231 cells. Specifically, we observe a significant decrease in K131cr, K156cr and K220cr of phosphoglycerate kinase 1 (PGK1) upon hypoxia. Enoyl-CoA hydratase 1 (ECHS1) is upregulated and interacts with PGK1, leading to the downregulation of PGK1 Kcr under hypoxia. Abolishment of PGK1 Kcr promotes glycolysis and suppresses mitochondrial pyruvate metabolism by activating pyruvate dehydrogenase kinase 1 (PDHK1). A low PGK1 K131cr level is correlated with malignancy and poor prognosis of breast cancer. Our findings show that PGK1 Kcr is a signal in coordinating glycolysis and the tricarboxylic acid (TCA) cycle and may serve as a diagnostic indicator for breast cancer.

The functional relevance of lysine crotonylation in cancer remains to be further explored. Here, the authors show that hypoxia-induced downregulation of PGK1 lysine crotonylation promotes glycolysis and suppresses mitochondrial pyruvate metabolism, contributing to breast cancer progression.

Details

Title
Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle
Author
Guo, Zihao 1 ; Zhang, Yang 2 ; Wang, Haoyue 2 ; Liao, Liming 3 ; Ma, Lingdi 2 ; Zhao, Yiliang 4 ; Yang, Ronghui 2   VIAFID ORCID Logo  ; Li, Xuexue 2 ; Niu, Jing 4 ; Chu, Qiaoyun 4 ; Fu, Yanxia 4 ; Li, Binghui 5   VIAFID ORCID Logo  ; Yang, Chuanzhen 6   VIAFID ORCID Logo 

 Capital Medical University, Beijing Institute of Hepatology, Beijing Youan Hospital, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X); Capital Medical University, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X) 
 Capital Medical University, Beijing Institute of Hepatology, Beijing Youan Hospital, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X) 
 Westlake Laboratory of Life Sciences and Biomedicine, Westlake Four-Dimensional Dynamic Metabolomics (Meta4D) Laboratory, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315) 
 Capital Medical University, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X) 
 Capital Medical University, Beijing Institute of Hepatology, Beijing Youan Hospital, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X); Capital Medical University, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X); Tianjin Medical University Cancer Institute and Hospital, Department of Cancer Cell Biology and National Clinical Research Center for Cancer, Tianjin, China (GRID:grid.411918.4) (ISNI:0000 0004 1798 6427) 
 Capital Medical University, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X); Westlake Laboratory of Life Sciences and Biomedicine, Westlake Four-Dimensional Dynamic Metabolomics (Meta4D) Laboratory, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315) 
Pages
6915
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3092133484
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.